Wound healing involves complex process at the cellular level. In case of chronic wounds, the healing time is prolonged due to infection and prevailing disease conditions. Wound care products assist such chronic wounds by speeding up the process of healing. The wound care market has experienced a paradigm shift from traditional wound management to active wound care.

The purpose of this report is to cover the description, definition and forecast of the global advanced wound care market. It involves deep dive analysis of market segmentation, which comprises of submarkets, products and end users. The global market is expected to reach USD 14.9 Billion by 2020 from USD 9.9 Billion in 2014, at a CAGR of 7.0% from 2015 to 2020. In 2014, North America dominated the market registering around 34.4% market share, and the region’s market is expected to grow at a CAGR of 6.9% during the forecast period. Factors such as increasing aging population, growing incidences of diabetes, technological advancements, and rising government initiatives are propelling the growth of this market.

By type, the global advanced wound care market is divided into dressings, therapy devices, and active wound care. The dressing segment accounted for the largest share of 47.8% of the global market in 2014. On the basis of application, the market is segmented into surgical wounds, ulcers, and others, of which the surgical wounds segment accounted for the largest share of 43.3% of the global market in 2014. By end user, the market is further classified into inpatient facilities and outpatient facilities. The inpatient facilities segment accounted for the largest market share of 72.2% in 2014.

http://www.marketsandmarkets.com/Market-Reports/advanced-wound-care-market-88705076.html

In-depth market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports, and interviews with industry experts and key opinion leaders, such as CEOs, directors, and marketing executives.

The major players in this market include Acelity L.P., Inc. (U.S.), Smith and Nephew Plc. (U.K.), Integra Lifesciences Corporation (U.S.), Mölnlycke Health Care (Sweden), ConvaTec, Inc. (U.S.), Coloplast Corp. (Denmark), Organogenesis Inc. (U.S.), Medline Industries, Inc. (U.S.), and MPM Medical, Inc. (RBC Life Sciences, Inc.) (U.S.). These companies have adopted various strategies, such as mergers & acquisitions and partnerships, among others, to achieve growth in the global advanced wound care market.